GO:0055015 ventricular cardiac muscle cell development: Chamber Specification, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0055015 describes the progression of a ventricular cardiac muscle cell from its formation to its mature state, including chamber-specific identity, proliferation, migration, and contractile maturation.
• Single-cell and spatial transcriptomics have revealed distinct ventricular cardiomyocyte subtypes and spatially organized cellular communities in the developing human heart.
• Chamber-specific transcription factors such as IRX4 and NRG1 signaling regulate ventricular cardiomyocyte migration, cell cycle, and myocardial patterning.
• Ventricular cardiac muscle cell development is central to understanding congenital heart defects, cardiomyopathy, and ischemia/reperfusion injury.
• Human ventricular cardiac organoids and stem cell-derived cardiomyocytes provide tractable models for studying ventricular development and disease.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal testing of genes involved in ventricular cardiac muscle cell development.
Description
GO:0055015, ventricular cardiac muscle cell development, is a biological process ontology term that defines the progression of a ventricular cardiac muscle cell over time, from its formation to the mature state. Ventricular cardiac muscle cells, or ventricular cardiomyocytes, are striated muscle cells responsible for the pumping action of the ventricle, the chamber that ejects blood out of the heart. Understanding this process is essential because disruptions in ventricular cardiomyocyte development underlie a range of congenital and acquired heart diseases. Recent advances in single-cell and spatial transcriptomics have begun to resolve the cellular diversity and spatial organization of the developing human heart, providing a high-resolution framework for studying ventricular cardiac muscle cell development. These studies have identified distinct ventricular cardiomyocyte populations and chamber-specific gene expression programs that are critical for normal heart function. For researchers, GO:0055015 provides a precise annotation for genes and pathways that control ventricular cardiomyocyte specification, proliferation, migration, maturation, and contractile function. This article synthesizes authoritative QuickGO data and verified PubMed literature to describe the mechanisms, key genes, disease relevance, and experimental models associated with ventricular cardiac muscle cell development.
ventricular cardiac muscle cell development At A Glance
| GO ID | GO:0055015 |
|---|---|
| GO term | ventricular cardiac muscle cell development |
| Ontology | biological_process |
| Synonym | ventricular cardiomyocyte development; ventricular heart muscle cell development |
| Definition | The process whose specific outcome is the progression of a ventricular cardiac muscle cell over time, from its formation to the mature state. |
| Major function | Specification, proliferation, migration, and maturation of ventricular cardiomyocytes for heart contraction |
| Related anatomy | Ventricle of the heart |
| Related cell type | Ventricular cardiac muscle cell (ventricular cardiomyocyte) |
What Is GO:0055015?
Ventricular cardiac muscle cell development (GO:0055015) is the biological process by which a ventricular cardiac muscle cell progresses from its initial formation to a fully mature state. This includes the specification of ventricular identity, proliferation and migration of ventricular cardiomyocyte precursors, and the structural and functional maturation of these cells to support the contractile demands of the ventricle. The term is specific to the ventricular chamber, distinguishing it from atrial or other cardiac muscle cell development.
Why Is ventricular cardiac muscle cell development Important in Cell Biology?
Ventricular cardiac muscle cell development is fundamental to heart formation and function, as the ventricle is the primary pump that drives blood circulation. Defects in this process can lead to congenital heart defects, cardiomyopathies, and increased susceptibility to ischemic injury. Understanding the molecular and cellular mechanisms of ventricular cardiomyocyte development is therefore critical for developing diagnostic markers and therapeutic strategies for heart disease.
• Ventricular cardiomyocytes are the main contractile cells of the heart and are essential for pumping blood out of the organ.
• Chamber-specific identity of ventricular cardiomyocytes is controlled by transcription factors such as IRX4, which marks ventricular myocardium during development.
• NRG1 signaling regulates ventricular cardiomyocyte migration and cell cycle, influencing myocardial growth and patterning.
• Single-cell transcriptomics has revealed distinct ventricular cardiomyocyte subtypes and their spatial organization in the developing human heart.
• Disruption of ventricular cardiac muscle cell development is associated with congenital heart defects and cardiomyopathy.
• Human ventricular cardiac organoids and stem cell-derived cardiomyocytes model ischemia/reperfusion injury and contractile dysfunction.
• Calcium handling and contractility dynamics in ventricular myocytes are key functional readouts of maturation and disease.
• Myocardial mesostructure and mesofunction studies provide insights into how ventricular tissue architecture supports contraction.
• Mutations in sarcomeric proteins, such as β-myosin R403Q, alter contraction in ventricular muscle and cardiomyocyte models.
• CRISPR gene editing enables precise modeling of genetic variants implicated in ventricular development and disease.
What Happens During ventricular cardiac muscle cell development?
Specification of Ventricular Identity
In simple terms: Early heart cells decide to become ventricular muscle cells rather than other heart cell types.
During heart development, progenitor cells acquire a ventricular-specific identity through the action of transcription factors and signaling pathways. IRX4 is a chamber-specific transcription factor that identifies a population of cells contributing to ventricular myocardium development. Single-cell and spatial transcriptomics of the developing human heart have revealed spatially organized cellular communities that define ventricular cardiomyocyte populations. These studies show that ventricular identity is established early and maintained through distinct gene regulatory networks.
Proliferation and Migration of Ventricular Cardiomyocytes
In simple terms: Ventricular muscle cells multiply and move to build the growing heart wall.
After specification, ventricular cardiomyocytes undergo proliferation and migration to expand the ventricular myocardium. NRG1 signaling regulates cardiomyocyte migration and cell cycle in ventricular development, as shown in genetic studies. Disruption of NRG1 signaling affects the number and positioning of ventricular cardiomyocytes, highlighting its role in myocardial growth. The developing human heart exhibits distinct spatial organization of proliferating and differentiating cardiomyocytes, as resolved by spatial transcriptomics.
Maturation of Contractile Apparatus
In simple terms: Ventricular muscle cells build the machinery needed to contract and pump blood.
As ventricular cardiomyocytes mature, they assemble sarcomeres and develop calcium handling and contractile dynamics characteristic of the ventricle. Studies in isolated ventricular myocytes have assessed calcium handling and contractility dynamics simultaneously, providing functional readouts of maturation. Mutations in sarcomeric proteins, such as the β-myosin R403Q mutation, alter contraction in porcine ventricular muscle and human stem cell-derived cardiomyocyte models. These findings link molecular maturation to contractile performance.
Chamber-Specific Gene Expression Programs
In simple terms: Ventricular cells turn on a unique set of genes that distinguish them from atrial cells.
Ventricular cardiomyocytes express chamber-specific genes that distinguish them from atrial cardiomyocytes. Transcriptional and cellular diversity of the human heart has been mapped by single-cell RNA sequencing, revealing distinct cardiomyocyte subtypes including ventricular populations. IRX4 expression marks ventricular myocardium and contributes to chamber-specific identity. These gene expression programs are essential for the functional specialization of the ventricle.
Spatial Organization and Cellular Communities
In simple terms: Ventricular muscle cells are arranged in specific patterns with other heart cells to form functional tissue.
The developing human heart is composed of spatially organized cellular communities that include ventricular cardiomyocytes, fibroblasts, endothelial cells, and other cell types. Spatial transcriptomics has revealed that ventricular cardiomyocytes are organized into distinct anatomical domains with specialized functions. Myocardial mesostructure and mesofunction studies further show how tissue architecture supports coordinated contraction. This spatial organization is critical for normal ventricular development and function.
Key Genes Involved in GO:0055015 ventricular cardiac muscle cell development
The following genes and proteins have been implicated in ventricular cardiac muscle cell development based on verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IRX4 | Chamber-specific transcription factor marking ventricular myocardium | Identifies ventricular cell population; knockout models show ventricular defects |
| NRG1 | Regulates cardiomyocyte migration and cell cycle in ventricular development | Genetic deletion affects ventricular myocardial growth |
| MYH7 | Encodes β-myosin heavy chain, a sarcomeric protein | R403Q mutation alters contraction in ventricular muscle and cardiomyocyte models |
| TNNT2 | Encodes cardiac troponin T, involved in calcium regulation of contraction | Mutations linked to cardiomyopathy; studied in stem cell-derived cardiomyocytes |
| ACTC1 | Encodes cardiac actin, a component of the sarcomere | Mutations affect contractile function in ventricular myocytes |
| MYBPC3 | Encodes myosin binding protein C, regulates sarcomere assembly | Mutations associated with hypertrophic cardiomyopathy |
| GATA4 | Transcription factor essential for heart development | Regulates ventricular cardiomyocyte gene expression |
| NKX2-5 | Homeobox transcription factor required for heart tube formation | Mutations cause congenital heart defects |
| TBX5 | Transcription factor involved in chamber specification | Expressed in ventricular myocardium; mutations cause Holt-Oram syndrome |
| MEF2C | Transcription factor promoting cardiomyocyte differentiation | Regulates sarcomeric gene expression |
| HAND1 | Transcription factor in ventricular cardiomyocyte differentiation | Knockout leads to ventricular hypoplasia |
| HAND2 | Transcription factor in cardiac development | Involved in ventricular trabeculation |
| SRF | Serum response factor regulating sarcomeric genes | Required for cardiomyocyte maturation |
| MYOCD | Myocardin, coactivator of SRF | Promotes smooth and cardiac muscle gene expression |
| CACNA1C | Voltage-gated calcium channel subunit | Mediates calcium influx in ventricular myocytes |
| RYR2 | Ryanodine receptor 2, calcium release channel | Essential for excitation-contraction coupling |
| ATP2A2 | SERCA2a calcium pump | Regulates calcium reuptake and relaxation |
| SCN5A | Voltage-gated sodium channel | Initiates action potential in ventricular myocytes |
How Is ventricular cardiac muscle cell development Regulated?
Ventricular cardiac muscle cell development is regulated by a combination of transcription factors, signaling pathways, and epigenetic mechanisms. NRG1 signaling controls cardiomyocyte migration and cell cycle during ventricular development. Chamber-specific transcription factors such as IRX4 establish and maintain ventricular identity. Single-cell transcriptomics has revealed that gene regulatory networks in ventricular cardiomyocytes are dynamically regulated during development. Calcium handling and contractility are regulated by ion channels and pumps such as CACNA1C, RYR2, and ATP2A2. Additionally, sarcomeric protein mutations can alter contractile regulation, as shown for the β-myosin R403Q mutation.
ventricular cardiac muscle cell development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MYH7 | Hypertrophic cardiomyopathy | Knock-in of R403Q mutation in human iPSC-derived cardiomyocytes |
| NKX2-5 | Congenital heart defects | Knockout in human cardiac organoids or mouse models |
| IRX4 | Ventricular chamber malformations | Knockout in zebrafish or mouse to study ventricular development |
| NRG1 | Ventricular hypoplasia | Conditional knockout in mouse ventricular myocardium |
| SCN5A | Ventricular arrhythmias | Point mutation knock-in in iPSC-derived cardiomyocytes |
Congenital Heart Defects
Disruptions in ventricular cardiac muscle cell development can lead to congenital heart defects, including ventricular septal defects and hypoplastic ventricles. Mutations in transcription factors such as NKX2-5, TBX5, and GATA4 are associated with congenital heart disease. IRX4, a ventricular-specific transcription factor, is critical for ventricular myocardium development, and its dysregulation may contribute to chamber-specific malformations.
Cardiomyopathy and Heart Failure
Abnormal ventricular cardiomyocyte development and maturation can result in cardiomyopathy. Mutations in sarcomeric genes such as MYH7, TNNT2, and MYBPC3 cause hypertrophic or dilated cardiomyopathy, affecting contractile function. Studies using human stem cell-derived cardiomyocytes with the β-myosin R403Q mutation have shown altered contraction, providing a model for disease mechanisms.
Ischemia/Reperfusion Injury
Ventricular cardiomyocytes are highly sensitive to ischemia/reperfusion injury, which occurs during myocardial infarction. Human ventricular cardiac organoids have been used to model myocardial ischemia/reperfusion injury with inflammatory response, revealing cellular responses and potential therapeutic targets. These models help study how ventricular cardiomyocytes respond to stress and injury.
Arrhythmias
Defects in ion channel function and calcium handling in ventricular cardiomyocytes can cause arrhythmias. Mutations in SCN5A, CACNA1C, and RYR2 are linked to ventricular arrhythmias and sudden cardiac death. Functional studies in isolated ventricular myocytes assess calcium handling and contractility dynamics, providing insights into arrhythmia mechanisms.
From ventricular cardiac muscle cell development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate ventricular cardiomyocyte proliferation? | Knockout of gene X in human iPSC-derived cardiomyocytes or mouse models |
| Does a specific point mutation in MYH7 alter contractility? | Point mutation knock-in (e.g., R403Q) in human iPSC-derived cardiomyocytes |
| Does gene Y control ventricular chamber identity? | Knock-in of fluorescent reporter (e.g., IRX4-GFP) in zebrafish or mouse |
| Does overexpression of gene Z enhance maturation? | Overexpression of gene Z in human cardiac organoids |
| What is the role of NRG1 in ventricular cardiomyocyte migration? | Conditional knockout or overexpression in mouse ventricular development |
| How do ventricular cardiomyocytes respond to ischemia/reperfusion? | Human ventricular cardiac organoids subjected to hypoxia/reoxygenation |
How to Study the ventricular cardiac muscle cell development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA-seq | Transcriptional diversity of ventricular cardiomyocytes | Identifying ventricular subtypes and gene programs |
| Spatial transcriptomics | Spatial organization of gene expression in heart tissue | Mapping cellular communities in developing ventricle |
| Calcium imaging and contractility assays | Calcium handling and contractile dynamics | Assessing maturation and disease in isolated ventricular myocytes |
| Human cardiac organoids | 3D tissue-like responses to injury and drugs | Modeling ischemia/reperfusion injury |
| iPSC-derived cardiomyocytes | Contractile function and electrophysiology | Studying sarcomeric mutations (e.g., R403Q) |
| Lineage tracing | Contribution of progenitor cells to ventricular myocardium | Identifying ventricular cell origins |
| Conditional knockout in mice | Gene function in ventricular development | Testing NRG1 signaling in vivo |
| Transcriptional profiling (bulk RNA-seq) | Global gene expression changes | Comparing ventricular vs atrial myocardium |
Single-Cell and Spatial Transcriptomics
Single-cell RNA sequencing and spatial transcriptomics have been used to map the cellular diversity and spatial organization of the developing human heart, including ventricular cardiomyocyte populations. These methods identify chamber-specific gene expression programs and reveal cellular communities that form the ventricle.
Functional Assays in Isolated Ventricular Myocytes
Isolated ventricular myocytes can be used to simultaneously assess calcium handling and contractility dynamics, providing direct functional readouts of maturation and disease. These assays are valuable for testing the effects of genetic mutations or pharmacological interventions.
Human Cardiac Organoids and Stem Cell-Derived Cardiomyocytes
Human ventricular cardiac organoids and iPSC-derived cardiomyocytes model ventricular development and disease, including ischemia/reperfusion injury and contractile dysfunction. These models enable mechanistic studies and drug testing in a human-relevant context.
Genetic Lineage Tracing and Reporter Models
Lineage tracing using chamber-specific markers such as IRX4 identifies ventricular cell populations and their contribution to myocardium development. Reporter models allow visualization of ventricular cardiomyocyte specification, migration, and maturation in vivo.
How CRISPR Can Be Used to Study GO:0055015 ventricular cardiac muscle cell development
Knockout
CRISPR knockout of genes such as IRX4, NRG1, or NKX2-5 in human iPSC-derived cardiomyocytes or animal models can test their requirement for ventricular cardiac muscle cell development. Knockout studies help determine whether a gene is essential for ventricular specification, proliferation, or maturation.
Point Mutation
CRISPR point mutation knock-in can introduce disease-associated variants, such as the β-myosin R403Q mutation in MYH7, into human iPSC-derived cardiomyocytes to study altered contractility and disease mechanisms. This approach provides isogenic controls for precise functional comparisons.
Knock-in
CRISPR knock-in of fluorescent reporters or epitope tags into endogenous loci, such as IRX4, enables lineage tracing and visualization of ventricular cardiomyocytes in developing heart models. Tagged knock-in lines also facilitate biochemical studies of protein interactions.
Overexpression
CRISPR-mediated overexpression or cDNA overexpression of candidate genes, such as NRG1 or transcription factors, can test sufficiency for promoting ventricular cardiomyocyte development or maturation. Overexpression models are useful for gain-of-function studies in cardiac organoids or stem cell-derived cardiomyocytes.
How EDITGENE Supports ventricular cardiac muscle cell development Research
Researchers studying ventricular cardiac muscle cell development-related genes often need to determine whether a candidate gene is causally involved in ventricular specification, proliferation, migration, or maturation. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation in human iPSC-derived cardiomyocytes, cardiac organoids, and animal models, accelerating functional validation and disease modeling.
Contact EDITGENE today to design your custom CRISPR model for ventricular cardiac muscle cell development research.
Frequently Asked Questions About ventricular cardiac muscle cell development
What is GO:0055015?
GO:0055015 is the Gene Ontology term for ventricular cardiac muscle cell development, describing the progression of a ventricular cardiomyocyte from formation to mature state.
What genes are involved in ventricular cardiac muscle cell development?
Key genes include IRX4, NRG1, NKX2-5, GATA4, TBX5, MYH7, TNNT2, and others involved in specification, proliferation, and maturation.
What is the role of IRX4 in ventricular development?
IRX4 is a chamber-specific transcription factor that identifies a cell population contributing to ventricular myocardium development.
How does NRG1 regulate ventricular cardiomyocytes?
NRG1 signaling regulates cardiomyocyte migration and cell cycle during ventricular development.
What diseases are linked to ventricular cardiac muscle cell development?
Congenital heart defects, cardiomyopathy, ischemia/reperfusion injury, and arrhythmias are linked to defects in this process.
How can I study ventricular cardiac muscle cell development in the lab?
Methods include single-cell RNA-seq, spatial transcriptomics, human cardiac organoids, iPSC-derived cardiomyocytes, and CRISPR gene editing.
What are human ventricular cardiac organoids?
They are 3D tissue models derived from human stem cells that mimic ventricular myocardium and can be used to study injury and disease.
What is the β-myosin R403Q mutation?
It is a mutation in MYH7 that alters contraction in ventricular muscle and human stem cell-derived cardiomyocyte models.
How is calcium handling measured in ventricular myocytes?
Calcium handling and contractility dynamics can be assessed simultaneously in isolated ventricular myocytes using imaging and force measurements.
What CRISPR models are available for ventricular development research?
Knockout, point mutation, knock-in, and overexpression models in iPSC-derived cardiomyocytes and organoids are available from EDITGENE.
Conclusion
Ventricular cardiac muscle cell development (GO:0055015) is a fundamental biological process that governs the formation and maturation of the heart's primary contractile cells. Advances in single-cell and spatial transcriptomics, human cardiac organoids, and CRISPR gene editing have provided unprecedented insights into the genes and mechanisms controlling ventricular cardiomyocyte specification, proliferation, migration, and maturation. These findings have direct implications for understanding congenital heart defects, cardiomyopathy, and ischemic injury. Continued research using precise genetic models will further elucidate the regulatory networks underlying ventricular development and inform therapeutic strategies for heart disease.
References
- 1. Farah EN et al.. 2024. Spatially organized cellular communities form the developing human heart.. Nature 627(8005):854-864 PMID: 38480880
- 2. Tucker NR et al.. 2020. Transcriptional and Cellular Diversity of the Human Heart.. Circulation 142(5):466-482 PMID: 32403949
- 3. Zhang L et al.. 2025. Modelling myocardial ischemia/reperfusion injury with inflammatory response in human ventricular cardiac organoids.. Cell Prolif 58(3):e13762 PMID: 39377453
- 4. Grego-Bessa J et al.. 2023. Nrg1 Regulates Cardiomyocyte Migration and Cell Cycle in Ventricular Development.. Circ Res 133(11):927-943 PMID: 37846569
- 5. Wilson AJ et al.. 2022. Myocardial mesostructure and mesofunction.. Am J Physiol Heart Circ Physiol 323(2):H257-H275 PMID: 35657613
- 6. Pérez-Treviño P et al.. 2020. Simultaneous assessment of calcium handling and contractility dynamics in isolated ventricular myocytes of a rat model of post-acute isoproterenol-induced cardiomyopathy.. Cell Calcium 86:102138 PMID: 31838436
- 7. Steczina S et al.. 2025. Molecular mechanisms of altered contraction with the β-myosin R403Q mutation in porcine ventricular muscle and a human stem cell-derived cardiomyocyte model.. J Mol Cell Cardiol 209:143-160 PMID: 41167329
- 8. Nelson DO et al.. 2014. Irx4 identifies a chamber-specific cell population that contributes to ventricular myocardium development.. Dev Dyn 243(3):381-92 PMID: 24123507
